Macrophage activation syndrome in juvenile systemic lupus erythematosus: An under-recognized complication?

Lupus

Volumn 16, Issue 8, 2007, Pages 587-592

  Pringe, A ^a,b   Trail, L ^a   Ruperto, N ^a   Buoncompagni, A ^a   Loy, A ^a   Breda, L ^a,c   Martini, A ^a,d   Ravelli, Angelo ^a,d  

^a G GASLINI INSTITUTE   (Italy)

^b HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE   (Argentina)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Childhood; Juvenile onset systemic lupus erythematosus; Macrophage activations syndrome; Paediatrics; Reactive haemophagocytic syndrome

Indexed keywords

CLINICAL FEATURE; DISEASE ASSOCIATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MACROPHAGE ACTIVATION SYNDROME; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE OF ONSET; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGE ACTIVATION; SYNDROME;

EID: 34548449453     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307079078     Document Type: Review

References (24)

1. Prieur A-M, Stéphan JL. Macrophage activation syndrome in children with joint diseases. Rev Rheum Engl Ed 1994; 61: 385-338.
2. Grom AA, Passo M. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr 1996; 129: 630-632.
3. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85: 421-426.
4. Stéphan JL, Koné-Paut I, Galanbrun C, Mouy R, Bader-Meunier B. Prieur A-M. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology 2001; 40: 1285-1292.
5. Ravelli A, Martini A. Macrophage activation syndrome. In Lehman TJA, Cimaz R eds. Pediatrics in systemic autoimmune diseases. Elsevier, 2007 (in press).
6. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002; 14: 548-552.
7. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum 2004; 50: 689-698.
8. Villanueva J, Lee S, Giannini EH et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005; 7: R30-R37.
9. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drug or infection. J Pediatr 1985; 106: 561-566.
10. Janka G, Zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology (Am Soc Hematol Educ Program) 2005; 82-88.
11. Athreya BH. Is macrophage activation syndrome a new entity? Clin Exp Rheumatol 2002; 20: 121-123.
12. Ramanan AV, Schneider R. Macrophage activation syndrome - what's in a name! J Rheumatol 2003; 30: 2513-2516.
13. Ravelli A, Viola S, De Benedetti F, Magni-Manzoni S, Tzialla C, Martini A. Dramatic efficacy of cyclosporine A in macrophage activation syndrome. Clin Exp Rheumatol 2000; 19: 108 (letter).
14. Lambotte O, Khellaf M, Harmouche H et al. Characteristic and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine 2006; 85: 169-182.
15. McCann LJ, Hasson N, Pilkington CA. Macrophage activation syndrome as an early presentation of lupus. J Rheumatol 2006; 33: 438-440 (letter).
16. Avcin T, Tse S, Schneider R, Ngan B, Silverman E. Macrophage activation syndrome as the presenting manifestation of rheumatic disease in childhood. J Pediatr 2006; 148: 683-686.
17. Sterba G, Rodriguez C, Sifontes S, Vigilanza P. Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis. J Rheumatol 2004; 31: 1014-1015.
18. Muise A, Tallett SE, Silverman ED. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? Pediatrics 2003; 112: e495.
19. Rigante D, Capoluongo E, Bertoni B et al. First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum 2007; 56: 658-661.
20. Ravelli A, Magni-Manzoni S, Pistorio A et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598-604.
21. Mouy R, Stephan J-L, Pillet P, Haddad E, Hubert P, Prieur A-M. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996; 129: 750-754.
22. Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996; 28: 275-278.
23. Morales PM, Jimenez BFJ, Yanes P, Rios D, Godinez R. Bone marrow with reactive histiocytosis, hemophagocytosis and storage histiocytes in systemic lupus erythematosus. Arthritis Rheum 1992; 35(Suppl): S239 (abstract).
24. Ravelli A, Viola S, De Benedetti F, Magni Manzoni S, Martini A. Visceral leishmaniasis as a cause of unexplained fever and cytopenia in systemic lupus erythematosus. Acta Paediatr 2002; 91: 246-247 (letter).